It significantly reduced the expression of APP and p-tau in the hippocampus of AD mice and improved spatial learning and memory abilities.464 A widely studied Ru(III) anticancer drug, KP1019 (60), reveals a unique anti-Aβ strategy. The gene discussed is MAPT; the disease is Alzheimer disease.